Evidence map›Paper›PMID 29441013›Full record

ArticleFrontiers in aging neuroscience2018

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.

Simona Daniele, Deborah Pietrobono, Jonathan Fusi, Annalisa Lo Gerfo, Eugenio Cerri, Lucia Chico, Caterina Iofrida, Lucia Petrozzi, Filippo Baldacci, Chiara Giacomelli and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Physical activity across the life course and neural biomarkers.Journal of Alzheimer's disease : JAD · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Epigenetic Modifications of theOxidative medicine and cellular longevity · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Simona DanieleDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Deborah PietrobonoDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Jonathan FusiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Annalisa Lo GerfoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Eugenio CerriDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Lucia ChicoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Caterina IofridaDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Lucia PetrozziDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Filippo BaldacciDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Chiara GiacomelliDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Fabio GalettaDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Gabriele SicilianoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Ubaldo BonuccelliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Maria L TrincavelliDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Ferdinando FranzoniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Claudia MartiniDepartment of Pharmacy, University of Pisa, Pisa, Italy.
University of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The loss of protein homeostasis that has been associated with aging leads to altered levels and conformational instability of proteins, which tend to form toxic aggregates. In particular, brain aging presents characteristic patterns of misfolded oligomers, primarily constituted of β-amyloid (Aβ), tau, and α-synuclein (α-syn), which can accumulate in neuronal membranes or extracellular compartments. Such aging-related proteins can also reach peripheral compartments, thus suggesting the possibility to monitor their accumulation in more accessible fluids. In this respect, we have demonstrated that α-syn forms detectable hetero-aggregates with Aβ or tau in red blood cells (RBCs) of healthy subjects. In particular, α-syn levels and its heteromeric interactions are modulated by plasma antioxidant capability (AOC), which increases in turn with physical activity. In order to understand if a specific distribution of misfolded proteins can occur in other blood cells, a cohort of human subjects was enrolled to establish a correlation among AOC, the level of physical exercise and the concentrations of aging-related proteins in platelets. The healthy subjects were divided depending on their level of physical exercise (i.e., athletes and sedentary subjects) and their age (young and older subjects). Herein, aging-related proteins (i.e., α-syn, tau and Aβ) were confirmed to be present in human platelets. Among such proteins, platelet tau concentration was demonstrated to decrease in athletes, while α-syn and Aβ did not correlate with physical exercise. For the first time, α-syn was shown to directly interact with Aβ and tau in platelets, forming detectable hetero-complexes. Interestingly, α-syn interaction with tau was inversely related to plasma AOC and to the level of physical activity. These results suggested that α-syn heterocomplexes, particularly with tau, could represent novel indicators to monitor aging-related proteins in platelets.

Indexed as

antioxidant capabilityphysical exerciseplateletsprotein misfoldingtauα-synucleinα-synuclein heterocomplexesβ-amyloid

Identifiers

PMID29441013
PMCPMC5797553
OpenAlexW2788825976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.